BRR OpCo’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $4.01M | Sell |
56,460
-1,579
| -3% | -$115K | 0.49% | 23 |
|
|
2022
Q2 | $4.47M | Buy |
58,039
+1,778
| +3% | +$135K | 0.53% | 21 |
|
|
2022
Q1 | $4.11M | Buy |
56,261
+46
| +0.1% | +$3.09K | 0.44% | 26 |
|
|
2021
Q4 | $3.5M | Buy |
56,215
+6,128
| +12% | +$359K | 0.38% | 30 |
|
|
2021
Q3 | $2.96M | Buy |
50,087
+1,713
| +4% | +$113K | 0.34% | 28 |
|
|
2021
Q2 | $3.23M | Buy |
48,374
+976
| +2% | +$63.6K | 0.36% | 26 |
|
|
2021
Q1 | $2.99M | Buy |
47,398
+58
| +0.1% | +$3.61K | 0.36% | 28 |
|
|
2020
Q4 | $2.94M | Buy |
47,340
+1,503
| +3% | +$92.4K | 0.43% | 25 |
|
|
2020
Q3 | $2.76M | Buy |
45,837
+1,228
| +3% | +$73.9K | 0.46% | 22 |
|
|
2020
Q2 | $2.62M | Buy |
44,609
+2,337
| +6% | +$140K | 0.45% | 25 |
|
|
2020
Q1 | $2.36M | Buy |
42,272
+86
| +0.2% | +$5.26K | 0.45% | 25 |
|
|
2019
Q4 | $2.71M | Buy |
42,186
+4,348
| +11% | +$249K | 0.39% | 27 |
|
|
2019
Q3 | $1.92M | Buy |
37,838
+306
| +0.8% | +$14.4K | 0.31% | 31 |
|
|
2019
Q2 | $1.7M | Buy |
37,532
+15,142
| +68% | +$705K | 0.27% | 35 |
|
|
2019
Q1 | $1.07M | Buy |
22,390
+939
| +4% | +$46.8K | 0.18% | 50 |
|
|
2018
Q4 | $1.11M | Sell |
21,451
-169
| -0.8% | -$9.08K | 0.23% | 37 |
|
|
2018
Q3 | $1.34M | Sell |
21,620
-189
| -0.9% | -$11.2K | 0.26% | 32 |
|
|
2018
Q2 | $1.21M | Sell |
21,809
-217
| -1% | -$11.7K | 0.33% | 32 |
|
|
2018
Q1 | $1.39M | Sell |
22,026
-379
| -2% | -$24.4K | 0.39% | 27 |
|
|
2017
Q4 | $1.37M | Sell |
22,405
-237
| -1% | -$14.8K | 0.38% | 28 |
|
|
2017
Q3 | $1.44M | Sell |
22,642
-545
| -2% | -$31.8K | 0.44% | 26 |
|
|
2017
Q2 | $1.29M | Sell |
23,187
-300
| -1% | -$16.3K | 0.42% | 30 |
|
|
2017
Q1 | $1.28M | Sell |
23,487
-365
| -2% | -$20K | 0.42% | 29 |
|
|
2016
Q4 | $1.39M | Sell |
23,852
-1,648
| -6% | -$90.1K | 0.45% | 27 |
|
|
2016
Q3 | $1.38M | Sell |
25,500
-332
| -1% | -$21.3K | 0.45% | 31 |
|
|
2016
Q2 | $1.9M | Sell |
25,832
-1,855
| -7% | -$131K | 0.64% | 22 |
|
|
2016
Q1 | $1.77M | Sell |
27,687
-647
| -2% | -$40.8K | 0.63% | 23 |
|
|
2015
Q4 | $1.95M | Sell |
28,334
-610
| -2% | -$40.3K | 0.72% | 24 |
|
|
2015
Q3 | $1.71M | Buy |
28,944
+491
| +2% | +$31.1K | 0.73% | 21 |
|
|
2015
Q2 | $1.89M | Sell |
28,453
-787
| -3% | -$51.9K | 0.77% | 21 |
|
|
2015
Q1 | $1.89M | Sell |
29,240
-57
| -0.2% | -$3.57K | 0.77% | 22 |
|
|
2014
Q4 | $1.73M | Sell |
29,297
-1,739
| -6% | -$98.1K | 0.69% | 22 |
|
|
2014
Q3 | $1.59M | Sell |
31,036
-3,870
| -11% | -$193K | 0.65% | 25 |
|
|
2014
Q2 | $1.66M | Buy |
34,906
+67
| +0.2% | +$3.3K | 0.7% | 25 |
|
|
2014
Q1 | $1.81M | Sell |
34,839
-1,140
| -3% | -$60.7K | 0.79% | 20 |
|
|
2013
Q4 | $1.91M | Sell |
35,979
-1,188
| -3% | -$60.5K | 0.83% | 20 |
|
|
2013
Q3 | $1.72M | Sell |
37,167
-1,551
| -4% | -$68.1K | 0.81% | 20 |
|
|
2013
Q2 | $1.73M | Buy |
+38,718
| New | +$1.68M | 0.83% | 18 |
|
Other funds holding BMY
BRR OpCo's BMY Position: Q3 2022 in Review
BRR OpCo reduced its Bristol-Myers Squibb (BMY) stake by 2.7% in Q3 2022, selling an estimated $115K and leaving 56,460 shares worth $4.01M. The position accounts for 0.49% of the portfolio, ranked #23.
BRR OpCo first reported a position in BMY in Q2 2013 and has held it in 38 quarters since. The position peaked at $4.47M in Q2 2022. 2,469 funds tracked by Wall St. Rank hold BMY as of Q3 2022.
- BRR OpCo held 56,460 shares of Bristol-Myers Squibb worth $4.01M as of Q3 2022.
- BRR OpCo sold 1,579 Bristol-Myers Squibb shares in Q3 2022, an estimated $115K.
- Bristol-Myers Squibb made up 0.49% of BRR OpCo's portfolio in Q3 2022, its #23 holding.
- BRR OpCo first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 38 quarters since.
- BRR OpCo's Bristol-Myers Squibb position peaked at $4.47M in Q2 2022.
- 2,469 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2022.
Based on BRR OpCo's 13F filing for Q3 2022, filed 8 Nov 2022.